Chu Lin

21PUBLICATIONS
10CO-AUTHORS
Molecular targetsRadiation therapyRespiratory diseasesMajor global burdens of diseaseCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 05, 2026
Placebo response on the weight change and its influencing factors in overweight or obesity with or without diabetes: a meta-analysis of 182 anti-obesity medications trials.

|Mar 05, 2026
The association between glucagon-like peptide-1 receptor agonists and reported musculoskeletal adverse events: a systematic review and meta-analysis of randomized controlled trials.

Meng Cao, Chu Lin, Xiaoling Cai

|Dec 13, 2025
Intensive blood pressure reduction but an increased risk of peripheral arterial disease: a systematic review and meta-analysis of randomized controlled trials.

Ruoyang Jiao, Chu Lin, Zonglin Li

|Nov 05, 2025
Weight Loss, Obesity Medication, and Risk of Obesity-Associated Cancer: A Meta-Analysis of Randomized Controlled Trials.

Chengwen Li, Chu Lin, Xiaoling Cai

|Oct 01, 2025
Characterizing echocardiographic abnormalities and their associated factors in patients with type 1 diabetes: a cross-sectional study.

Wenfeng Yang, Chu Lin, Xiaoling Cai

|Jul 09, 2025
Glucagon-like peptide-1 receptor agonist treatment associated weight fluctuation and influencing factors in patients with overweight or obesity.

Jingxuan Wang, Chu Lin, Xiaoling Cai

Pageof 4

Frequent Collaborators

19 joint publications

Xiaoling Cai

15 joint publications

Linong Ji

5 joint publications

Wenjia Yang

4 joint publications

Zonglin Li